Ahmad Naim

1.1k total citations
45 papers, 781 citations indexed

About

Ahmad Naim is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Ahmad Naim has authored 45 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 12 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Ahmad Naim's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers), Hemoglobinopathies and Related Disorders (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ahmad Naim is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers), Hemoglobinopathies and Related Disorders (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ahmad Naim collaborates with scholars based in United States, France and Italy. Ahmad Naim's co-authors include Jennifer H. Lofland, Jean‐Jacques Kiladjian, Srđan Verstovšek, Ruben A. Mesa, Dilan Paranagama, Alessandro M. Vannucchi, Candace Gunnarsson, John A. Rizzo, Claire Harrison and Jason Gotlib and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Ahmad Naim

41 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmad Naim United States 15 390 322 215 194 99 45 781
Antonio Torres Spain 18 319 0.8× 662 2.1× 226 1.1× 49 0.3× 147 1.5× 44 1.2k
Diane G. Hillman United States 14 265 0.7× 288 0.9× 253 1.2× 35 0.2× 48 0.5× 26 985
Ida Carmosino Italy 15 327 0.8× 587 1.8× 231 1.1× 134 0.7× 163 1.6× 83 822
Avril A. Fitzgerald Canada 11 79 0.2× 357 1.1× 156 0.7× 487 2.5× 73 0.7× 15 863
Annelies E. van Ede Netherlands 10 344 0.9× 479 1.5× 82 0.4× 551 2.8× 40 0.4× 19 1.1k
Claire Bethune United Kingdom 13 388 1.0× 157 0.5× 70 0.3× 150 0.8× 37 0.4× 25 683
Marissa Blum United States 9 58 0.1× 51 0.2× 192 0.9× 157 0.8× 50 0.5× 11 650
Stephanie Farnia United States 13 160 0.4× 356 1.1× 88 0.4× 21 0.1× 211 2.1× 22 669
Jonathan Cullis United Kingdom 14 359 0.9× 746 2.3× 134 0.6× 90 0.5× 137 1.4× 28 970
C. Christopher Hook United States 11 388 1.0× 304 0.9× 169 0.8× 179 0.9× 28 0.3× 22 589

Countries citing papers authored by Ahmad Naim

Since Specialization
Citations

This map shows the geographic impact of Ahmad Naim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Naim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Naim more than expected).

Fields of papers citing papers by Ahmad Naim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Naim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Naim. The network helps show where Ahmad Naim may publish in the future.

Co-authorship network of co-authors of Ahmad Naim

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Naim. A scholar is included among the top collaborators of Ahmad Naim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Naim. Ahmad Naim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holtan, Shernan G., Jingbo Yu, Hannah Choe, et al.. (2022). Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review. Bone Marrow Transplantation. 57(10). 1581–1585. 23 indexed citations
2.
Holtan, Shernan G., Jingbo Yu, Dilan Paranagama, et al.. (2022). Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study. Bone Marrow Transplantation. 57(9). 1399–1404. 9 indexed citations
3.
Huarte, Eduardo, Roddy S. O’Connor, Michael T. Peel, et al.. (2020). Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy. Clinical Cancer Research. 26(23). 6299–6309. 67 indexed citations
4.
5.
Boccia, Ralph V., Pedro Sanz-Altamira, Khuda Dad Khan, et al.. (2017). Examining the Frequency of Phlebotomy in Patients with Polycythemia Vera (PV) in the United States: An Analysis of Data from the REVEAL Study. Blood. 130. 5271–5271. 2 indexed citations
6.
Grunwald, Michael R., John M. Burke, David J. Kuter, et al.. (2017). Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study. Blood. 130. 2924. 1 indexed citations
7.
Verstovšek, Srđan, Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2017). Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy. Leukemia Research. 56. 52–59. 22 indexed citations
8.
Verstovšek, Srđan, Jason Gotlib, Ruben A. Mesa, et al.. (2017). Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses. Journal of Hematology & Oncology. 10(1). 156–156. 193 indexed citations
9.
Vannucchi, Alessandro M., Srđan Verstovšek, Paola Guglielmelli, et al.. (2017). Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study. Annals of Hematology. 96(7). 1113–1120. 64 indexed citations
10.
Gunnarsson, Candace, Jie Chen, John A. Rizzo, et al.. (2015). The Employee Absenteeism Costs of Rheumatoid Arthritis. Journal of Occupational and Environmental Medicine. 57(6). 635–642. 22 indexed citations
11.
Parasuraman, Shreekant, Ahmad Naim, Dilan Paranagama, et al.. (2015). Financial Burden of Myeloproliferative Neoplasms on Patients: Results from the MPN Landmark Survey in the United States. Blood. 126(23). 5561–5561. 2 indexed citations
12.
Siegel, Corey A., et al.. (2015). Novel Statistical Approach to Determine Inflammatory Bowel Disease: Patients’ Perspectives on Shared Decision Making. Patient. 9(1). 79–89. 31 indexed citations
13.
Siegel, Corey A., et al.. (2015). Gastroenterologists’ Views of Shared Decision Making for Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 60(9). 2636–2645. 29 indexed citations
14.
Parasuraman, Shreekant, et al.. (2015). Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: a chart review. Experimental Hematology and Oncology. 5(1). 3–3. 20 indexed citations
15.
Page, Robert L., Vahram Ghushchyan, Brian Gifford, et al.. (2014). Hidden Costs Associated With Venous Thromboembolism. Journal of Occupational and Environmental Medicine. 56(9). 979–985. 13 indexed citations
16.
Rizzo, John A., Jie Chen, Candace Gunnarsson, Ahmad Naim, & Jennifer H. Lofland. (2014). Adjusting for comorbidities in cost of illness studies. Journal of Medical Economics. 18(1). 12–28. 22 indexed citations
17.
Page, Robert L., Vahram Ghushchyan, Brian Gifford, et al.. (2013). The Economic Burden of Acute Coronary Syndromes for Employees and Their Dependents. Journal of Occupational and Environmental Medicine. 55(7). 761–767. 14 indexed citations
18.
Allen, Harris, William B. Bunn, & Ahmad Naim. (2012). The Self-Reported Health and Productivity Burden of Autoimmune Disorders at a Major Self-Insured Employer. Journal of Occupational and Environmental Medicine. 54(9). 1049–1063. 13 indexed citations
19.
Bunn, William B., Gregg M. Stave, Harris Allen, & Ahmad Naim. (2010). Evidence-Based Benefit Design: Toward a Sustainable Health Care Future for Employers. Journal of Occupational and Environmental Medicine. 52(10). 951–955. 8 indexed citations
20.
Bunn, William B., Harris Allen, Gregg M. Stave, & Ahmad Naim. (2010). How to Align Evidence-Based Benefit Design With the Employer Bottom-Line: A Case Study. Journal of Occupational and Environmental Medicine. 52(10). 956–963. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Torres Breakdown of academic impact, for papers by Diane G. Hillman Breakdown of academic impact, for papers by Ida Carmosino Breakdown of academic impact, for papers by Avril A. Fitzgerald Breakdown of academic impact, for papers by Annelies E. van Ede Breakdown of academic impact, for papers by Claire Bethune Breakdown of academic impact, for papers by Marissa Blum Breakdown of academic impact, for papers by Stephanie Farnia Breakdown of academic impact, for papers by Jonathan Cullis Breakdown of academic impact, for papers by C. Christopher Hook
Rankless by CCL
2026